2021 CMSC Annual Meeting

Tag: 7437DMT31Poster-Disease-modifying TherapyFrancis C Staskon

Poster-Disease-modifying Therapy

Adherence to Multiple Sclerosis Disease Modifying Therapies Using Pharmacy Quality Alliance Criteria and Medical Costs or Hospitalizations in an Administrative Database.

Background: Evidence is needed that adherence to disease-modifying therapies (DMT) for multiple sclerosis (MS) can reduce total medical...

Read More